Pacira BioSciences, Inc. PCRX Outside of the U.S. — Fixed assets, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s outside of the u.s. — fixed assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s outside of the U.S. — fixed assets, net?
- Pacira BioSciences, Inc. (PCRX) reported outside of the U.S. — fixed assets, net of $41M in Q1 2026.
- How has Pacira BioSciences, Inc.'s outside of the U.S. — fixed assets, net changed year-over-year?
- Pacira BioSciences, Inc.'s outside of the U.S. — fixed assets, net decreased by 18.0% year-over-year, from $50M to $41M.
- What does outside of the U.S. — fixed assets, net mean?
- This metric represents the net book value of property, plant, and equipment located in geographic regions outside of the company's primary domestic market. It reflects the capital investment in physical infrastructure, such as manufacturing facilities or distribution centers, required to support international operations and global supply chain logistics. Monitoring this figure helps investors assess the company's geographic footprint and the scale of its long-term asset commitment to non-domestic markets.